Skip to content

Pilot Study to Assess Safety and Feasibility of Normothermic Machine Perfusion In Liver Transplantation

A Pilot Study to Assess Safety and Feasibility of Normothermic Machine Perfusion In Liver Transplantation With Modified Procurement and Implantation Technique

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR-OPN-17012090
Enrollment
Unknown
Registered
2017-07-23
Start date
2017-07-22
Completion date
Unknown
Last updated
2017-07-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver transplantation

Interventions

Machine perfusion:Livers perserved using machine perfusion, with modified organ procurement and implantation technique

Sponsors

The First Affiliated Hospital of Sun Yat-sen University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
14 Years to 80 Years

Inclusion criteria

Inclusion criteria: (1) Donor aged 14-60 years old, recipient aged 14-80 years old; (2) The donors are brain death donors; (3) Primary liver transplant reipients; (4) The recipient and family agree to receive livers preserved using machine perfusion

Exclusion criteria

Exclusion criteria: (1) Combined organ transplantation or multivisceral transplantation; (2) ABO-hblood type mismatch; (3) Vessel variants leading to inability to NMP perfuse the livers; (4) Without willingness or ability to comply with the study procedure.

Design outcomes

Primary

MeasureTime frame
Peak AST level in the first 7 days post-transplantation;

Secondary

MeasureTime frame
Peak ALT, Tbil, INR levels within the first week post-transplantation;Early allograft dysfunction;Primary non-function;ischemic-type biliary lesion;graft survival;patient survival;histology of liver grafts;

Countries

China

Contacts

Public ContactXiaoshun He

The First Affiliated Hospital of Sun Yat-sen University

gdtrc@163.com+86 20 87306082

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026